- Tabor Network
Contributors
Tiffany TraderEditorial Director
Jamie HamptonManaging Editor
Kevin JacksonContributing Editor
John RussellContributing Editor
Alex WoodieContributing Editor
Douglas EadlineContributing Editor
Ali AzharContributing Editor
Drew JollyAssistant Editor
NEC Bio
NEC Bio Leverage GenAI to Boost TCR Binding Efficacy, Presented at SITC 2024
TOKYO, Nov. 7, 2024 -- Utilizing proprietary generative AI technology, NEC Bio has successfully modified T cell receptors (TCRs) to increase their efficacy. This achievement marks a major step ...Full Article